Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients With Hypophosphatasia

NCT05890794 is registered in ClinicalTrials.gov with AM-Pharma as lead sponsor.

NCT NCT05890794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients With Hypophosphatasia
Lead sponsor
AM-Pharma
Phase
Phase 1/2
Overall status
Completed
Start date
May 15, 2023
Completion date
July 12, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatasia